Clinical Trials
4 trialsNCT00421395 2021-08-16
Safety Study of NHL With 90Y-hLL2 IgG
Gilead Sciences
Phase 1/2 Completed
NCT00098839 2017-12-12
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
Children's Oncology Group
Phase 1/2 Completed
NCT01279707 2014-07-14
MARALL
Queen Mary University of London
Phase 1/2 Unknown
NCT01354457 2014-06-25
RIT 90YEpra
Nantes University Hospital
Phase 1/2 Unknown